Ключевые слова:
полинаркомания, неврозоподобные расстройства, биоакустическая коррекция, неаддиктивная фармакотерапия, тревога, астения, MoCA, qЭЭГ.Библиографические ссылки
1. Mateu-Mollá J., Pérez-Gálvez B., Villanueva-Blasco V.J. Pharmacological treatment for substance use disorder: A systematic review. Addictive Behaviors. 2025; 161:108242. doi: 10.1016/ j. addbeh.2024.108242.
2. IUPHAR Review: New strategies for medications to treat substance use disorders. Pharmacological Research. 2024; 200:107078. doi: 10.1016/ j. phrs.2024.107078.
3. Fathi M., Ebrahimi M.N., Banazadeh M., Shirvani A., Kamalahmadi N., Amiri H., Talaei A. A systematic review on the role of EEG and fMRI-Neurofeedback training in the treatment of substance use disorders and behavioral addiction. Psychiatry Research. 2025; 349:116474. doi: 10.1016/j.psychres.2025.116474.
4. Nielsen S., Gowing L., Sabioni P., Le Foll B. Pharmacotherapies for cannabis use disorder. Cochrane Database of Systematic Reviews. Updated evidence to May 2024.
5. Imperio C.G., Levin F.R., Martinez D. The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists. American Journal of Psychiatry. 2024;181(11). doi: 10.1176/appi.ajp.20231023.
6. Nardi W.R., Kelly P.J., et al. A systematic review and meta-analysis of psychosocial interventions for persons with comorbid anxiety and substance use disorders. Journal of Substance Use and Addiction Treatment. 2024; 165:209442. doi: 10.10 16/j.josat.2024.209442.
7. Alayoubi M., Henry B.A., Cahill C.M., et al. Exploring Novel Pharmacotherapy Candidates for Cannabis Use Disorder: Uncovering Promising Agents on the Horizon by Mechanism of Action. Drugs. 2024; 84:1395–1417.
8. Sokhadze T.M., Cannon R.L., Trudeau D.L. EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research. Applied Psychophysiology and Biofeedback. 2008;33(1):1–28. doi:10.1007 /s10484-007-9047-5.